Discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA) recently released.
DAIA would regulate in vitro clinical tests, defined in the draft as a laboratory test protocol or finished product intended for clinical use in the collection, preparation, analysis, or in vitro clinical examination of human specimens for the purpose of identifying, screening, measuring, detecting, predicting, monitoring, or assisting in selecting treatment for a disease or other condition. DAIA is intended to establish a flexible, risk-based approach to regulation of IVCTs.
Covington & Burling LLP
Elizabeth Guo is an associate in the Food Drug and Device Group with Covington & Burling LLP.
All of your training, right here at Lorman.
Pay once and get a full year of unlimited training in any format, any time!
- Live Webinars
- OnDemand Webinars
- MP3 Downloads
- Course Manuals
- Audio Recordings*
- Executive Reports
- White Papers and Articles
- Sponsored Live Webinars
Additional benefits include:
- State Specific Credit Tracker
- Members Only Newsletter
- All-Access Pass Course Concierge
* For audio recordings you only pay shipping
Questions? Call 877-296-2169 to speak with a real person.